Sino-Argi Leading Biosciences (603970) — Free Cash Flow Generation Index
Sino-Argi Leading Biosciences (603970) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of CN¥700.89 Million represents 1% of operating cash flow (CN¥702.54 Million). See Sino-Argi Leading Biosciences short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sino-Argi Leading Biosciences Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Sino-Argi Leading Biosciences across 10 annual periods. Explore debt repayment capacity of Sino-Argi Leading Biosciences to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year Free Cash Flow Generation Index for Sino-Argi Leading Biosciences. For the full company profile including market capitalisation, see 603970 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.99x | CN¥305.21 Million | CN¥307.40 Million | CN¥2.18 Million | ▼ -0.5% |
| 2022 | 1.00x | CN¥1.53 Billion | CN¥1.54 Billion | CN¥3.44 Million | ▲ +1.0% |
| 2021 | 0.99x | CN¥321.43 Million | CN¥325.42 Million | CN¥3.99 Million | ▲ +3.2% |
| 2020 | 0.96x | CN¥337.13 Million | CN¥352.12 Million | CN¥14.99 Million | ▼ -3.1% |
| 2019 | 0.99x | CN¥216.23 Million | CN¥218.90 Million | CN¥2.67 Million | ▲ +14.4% |
| 2018 | 0.86x | CN¥56.70 Million | CN¥65.69 Million | CN¥8.99 Million | ▼ -3.4% |
| 2017 | 0.89x | CN¥463.44 Million | CN¥518.83 Million | CN¥55.39 Million | ▲ +17.9% |
| 2016 | 0.76x | CN¥115.37 Million | CN¥152.22 Million | CN¥36.85 Million | ▼ -10.5% |
| 2014 | 0.85x | CN¥34.24 Million | CN¥40.41 Million | CN¥6.17 Million | ▼ -13.9% |
| 2012 | 0.98x | CN¥107.70 Million | CN¥109.43 Million | CN¥1.74 Million | — |